Keryx Biopharmaceuticals (NASDAQ:KERX)
A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
pchop123
(76.57)
Submitted: 6/17/2013 1:44:50 PM :
Start Price:
$7.50
KERX Score:
+1.14
time for more upside
Recs
zzlangerhans
(99.74)
Submitted: 6/14/2013 12:43:41 PM :
Start Price:
$7.03
KERX Score:
+7.38
Now that the GSK takeout rumor has been put to rest, the debate on Zerenex can return to the more rational concerns over IP protection and commercial viability against generic competition. These are certainly valid concerns but I believe they will be muted once the Zerenex NDA and MAA are submitted next quarter, only to resurface with a vengeance after likely FDA and EMA approval.
Recs
getrichdietrying
(72.48)
Submitted: 6/6/2013 2:33:12 PM :
Start Price:
$7.56
KERX Score:
+1.69
Lets try again and this time let's hope investors sell of on the dangerous investment this is.
Recs
TMFBlacknGold
(99.41)
Submitted: 5/29/2013 2:34:11 PM :
Start Price:
$7.22
KERX Score:
+3.41
Is Zerenex even produced biologically? Why is this company called Keryx "Biopharmaceuticals"? I think its just a ploy to attract investors. Anyway, Zerenex should get approved no problem. I just like to remind people that approval isn't the end game (marketing, drug access, etc) and that the company has 0 drugs in the pipeline.
Recs
baselineace
(20.50)
Submitted: 4/20/2013 1:41:14 AM :
Start Price:
$9.48
KERX Score:
+29.53
Another one of these companies with no sales... Oh dear.
Recs
Atwsdrl2012G
(31.54)
Submitted: 4/10/2013 3:25:05 AM :
Start Price:
$8.19
KERX Score:
+12.32
A Phara with 1med aimed at treating a side effect that is already reasonably well treated is cruising into a price war for a small area. I'd wait for this to be recommended for approval, let prices rise a week and buy 6 month puts. Did I mention that funding for this is almost 100% governmental the world around. If I were advise congress I'd ask their main computer and Kerex to bid for a5 year exclusive except allergies and take the lowest bid and limit use to patient in whom calcium has failed after 6 months.
Recs
Litigation
(24.71)
Submitted: 3/16/2013 7:15:33 PM :
Start Price:
$7.25
KERX Score:
-2.27
Price Target: $13
Recs
AlanBeardface
(44.48)
Submitted: 3/8/2013 9:53:29 PM :
Start Price:
$7.34
KERX Score:
+2.87
Overvalued after HUGE pop.
Recs
scrubs62074
(86.12)
Submitted: 1/23/2013 2:03:57 PM :
Start Price:
$3.81
KERX Score:
+88.27
High volume breakout 1/23/13
Recs
NHWeston102
(69.03)
Submitted: 7/6/2012 10:13:26 PM :
Start Price:
$1.93
KERX Score:
+270.24
Outclassed in all its categories but a fair buy-out candidates.
Recs
Recs
TXKL
(< 20)
Submitted: 5/16/2012 4:05:00 PM :
Start Price:
$1.85
KERX Score:
+284.88
Big buyout rumors.
Recs
someboy0808
(< 20)
Submitted: 5/11/2012 6:47:34 PM :
Start Price:
$1.98
KERX Score:
+259.39
Top line Positive phase 3 drug report from Japan, and 100million license fee, you know this company is not going down any time soon!
Recs
Recs
Stef100000
(< 20)
Submitted: 4/10/2012 1:22:13 PM :
Start Price:
$1.42
KERX Score:
-411.64
No future
Recs
Recs
WRXkid
(63.75)
Submitted: 3/29/2012 2:01:49 PM :
Start Price:
$4.83
KERX Score:
+38.62
Possible positive outcome of clinical trials for perifosine.
Recs
saulucy20
(< 20)
Submitted: 3/16/2012 6:02:54 AM :
Start Price:
$4.18
KERX Score:
+63.71
Phase 3 on Perifosine
Recs
RBuskey106
(30.05)
Submitted: 3/14/2012 10:42:20 PM :
Start Price:
$4.10
KERX Score:
+67.03
Betting on perifosine for the short term bump
Recs
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 76 : 1 2 3 4 Next »